Veriheal

APRIL 23, 2024

Report: Gen Z Would Rather Smoke Cannabis Than Consume Alcohol To collect this data, Veriheal surveyed thousands of patients between the ages of 15 and 27 who signed up for our services between March 2023 and April 2024. Gen Z is drinking far less alcohol, and many of them don’t use it at all.

Chronic Pain 109

Chronic Pain Data Edibles Sleep 109

Illinois News Joint

AUGUST 4, 2023

Headset , a data platform for the cannabis economy, recently released a report that examined the Illinois cannabis market. According to Headset, “This report analyzes detailed data on thousands of products in the Illinois market to determine how it compares to other states. on July 1, 2022, and ended at $13.77 compared to 17.3%

Extraction 76

Extraction Data Edibles Cannabis 76

Cannabis Law Report

MAY 14, 2022

Access to banking is a well-known issue for the cannabis industry and the repeated efforts to obtain the bill’s congressional passage over the past few years remains a hot topic for industry insiders and participants. The program was officially adopted during the 2022 legislative session.

Banking 52

Banking Recreational Research and Development Cannabis 52

Veriheal

SEPTEMBER 22, 2022

During this time, researchers conducted studies on a wide range of topics. A 2022 study published in the Journal of Cannabis Research explored cannabis consumption and COVID-19. The interest in this specific topic is the result of the immunomodulatory properties that cannabis possesses.

Consumption 109

Consumption Cannabis Topical Data 109

Cannabis Law Report

APRIL 21, 2022

Richard Quansah Amissah of the Ontario Veterinary College at the University of Guelph in Ontario, Canada, and colleagues present these findings in the open-access journal PLOS ONE on April 20, 2022. The authors add: “This is an important topic to study in the light of recent legalization of cannabis in Canada and across multiple states.

Pets 52

Pets Research and Development Topical Consumption 52

Cannabis Law Report

MARCH 3, 2022

Former President Bill Clinton has apparently been hearing a lot about the therapeutic potential of CBD products for pain management lately, and, according to a now-deleted media report, said at a recent conference appearance that broad interest in the topic should spur regulators to develop standards for the cannabinoid.

Media 52

Media CBD Events THC 52

Canna Law Blog

SEPTEMBER 18, 2023

The public likes it too: here’s a November 2022 Data for Progress poll revealing that “By a +65-point margin, voters support ensuring that banks do not discriminate against legitimate marijuana-related businesses.” Specifically, SAFE Banking was introduced in 2017 and it passed the House seven times (seven times!)

Banking 82

Banking Access Business Compliance 82

Cannabis Law Report

APRIL 28, 2022

Wednesday, May 25, 2022 | 1:00 p.m. Industry-leading targeting and marketing communication experts will discuss: > Harnessing data to find your ideal audience. > Each session will feature a specific topic, discuss the legal and business implications and provide insight on key matters. to 2:00 p.m. About the Program.

Research and Development 52

Research and Development Sleep Banking Cannabis 52

Veriheal

MARCH 8, 2022

Adults age 21 and over have been legally allowed to purchase a maximum of one ounce of recreational cannabis in Montana since January 1, 2022. Furthermore, data released by the Montana Department of Revenue indicates that statewide recreational cannabis sales remained level through the month of January – resting somewhere between $2.6

Programs 98

Programs Recreational Edibles Tincture 98

Cannabis Law Report

FEBRUARY 17, 2022

16, 2022 /PRNewswire/ — The National Underwriter Company, an ALM business, is launching the third course in the six-course Cannabis Insurance Coverage Specialist (CICS) designation, Understanding and Handling Cannabis Insurance Claims. Third module in the Cannabis Insurance Coverage Specialist (CICS) designation. NEW YORK , Feb.

Media 52

Media Topical Business Data 52

Cannabis Law Report

AUGUST 12, 2022

The rule does not apply to topical products, but it would treat as marijuana most full and broad spectrum hemp products. Additionally, NASC pointed out that robust data shows that properly manufactured hemp food and feed products do not pose high risk to animals for negative health consequences.

Hemp 52

Hemp THC Food Legislation 52

The Cannigma

JULY 9, 2023

A 2022 systematic review and meta-analysis that reviewed data from approximately 5.5 That said, there is currently very little scientific data available on the effects of CBD during pregnancy, and virtually no human data. 16 Do edible and topical cannabis products stunt growth? appeared first on The Cannigma.

Research and Development 68

Research and Development THC Cannabinoids Topical 68

Cannabis Law Report

APRIL 25, 2019

Seems to be this week’s hot topic after Canopy mentioned their deal to acquire Acreage if Federal legislation goes through. MedMen acquired PharmaCann, a dispensary chain, for $682 million in equity in December 2018 — one of nine deals by MedMen since the beginning of 2018, according to Mergermarket data.

Data 58

Data Retail Topical Edibles 58

The Cannigma

OCTOBER 6, 2022

Cannabis use and pregnancy is a tough topic. Refusing to have a conversation around this topic only continues to fuel the stigma of cannabis use. CBD topicals may provide a better option for pregnant and breastfeeding women over Tylenol or other OTC pain medications.

CBD 99

CBD Research and Development Topical THC 99

Cannabis Law Report

DECEMBER 20, 2021

First Patient Expected to be Enrolled by Q2 of 2022. Data To Support Regulatory Filings in the United States. The study will take place in Canada with a CTA filing and enrollment of the first patient anticipated by Q2 of 2022. BERWYN, Pa.–(BUSINESS Forward-Looking Statement.

Clinical Trials 52

Clinical Trials Chronic Pain Pharmaceutical Data 52

Cannabis Law Report

JUNE 3, 2021

The results from this study will provide validating data on the efficacy of the Company’s products in reducing pain and improving joint mobility in dogs. The Company expects the full study to be complete by the Spring 2022. cbdMD’s Paw CBD brand is one of the leading CBD animal health brands in the U.S. “It

Programs 83

Programs Pets Tincture CBD 83

Cannabis Law Report

MAY 10, 2022

11 May 2022. First academic study of national medicinal cannabis data. Using data from the Therapeutic Goods Administration (TGA) – Australia’s Special Access Scheme B, the researchers found the other two top reasons for prescriptions were pain and sleep disorders. Here’s the Uni of Sydney press release.

Medicine 52

Medicine Clinical Trials Sleep Data 52

Cannabis Law Report

AUGUST 3, 2021

In addition to FDM and e-commerce, the Transaction provides added distribution channels, increasing HempFusion’s 5 channel strategy to 6 channels and bolstering topical product distribution sales. Robust eCommerce platform drives over 17,000 average monthly sessions, and nearly $2.0 Chief Executive Officer of HempFusion. “We

Research and Development 105

Research and Development Topical Events Compliance 105

Cannabis Law Report

MAY 29, 2022

Celebrated author Michael Pollan has published two bestselling books on the topic: How to Change Your Mind and This is Your Mind on Plants. The complex regulatory challenges around researching controlled substances have been a hot topic in recent years because of interest around medical marijuana. 1, 2022), [link]. [14]

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

JUNE 1, 2021

Remains on track to achieve positive Adjusted EBITDA during the second half of FY 2022. opportunities in Fiscal 2022.” In Q1 2022, Canopy has expanded its portfolio of THC beverages with Tweed Iced Tea beverages (available in lemon and raspberry flavors, both with 5 mg THC) now shipping. Net revenue. Adjusted EBITDA 3.

Data 95

Data Vaping Supply Chain Business 95

Cannabis Law Report

AUGUST 25, 2021

Sagely Naturals”), (together the “Acquisitions”) for fiscal 2021 and 2022. million in fiscal 2021 and USD$20 million to $25 million in fiscal 2022 due in large part to the Company’s expansion plans over the next 18 months and beyond. million in revenue. million and $13.5 pull week ending 5/22/21)]. “I

Retail 111

Retail Supply Chain Research and Development Events 111

The Cannigma

FEBRUARY 1, 2023

The extract, which has come to be known as Rick Simpson Oil (RSO) , is highly potent, dense, and usually administered orally, sublingually, or topically. Only recently (2022) have laws governing cannabis research in the US become less restrictive. inhalation vs edible) on which we lack clinical data.

Clinical Trials 145

Clinical Trials Research and Development Therapy Cannabinoids 145

Cannabis Law Report

DECEMBER 14, 2021

Starting in the first quarter of 2022, this initiative, in conjunction with the Company’s strong revenue growth, is expected to help drive the business towards profitability. HempFusion proudly launched its CBD ingestibles (75 stores) and OTC Topicals into 400 Southeastern Grocers, Inc.’s Retail Update.

Supply Chain 52

Supply Chain Retail Topical Research and Development 52

Cannabis Law Report

JUNE 12, 2022

Legalising cannabis is a topic that is rife with debate. In April 2022, Biden issued ‘75 prison sentence communications’ and three pardons to individuals with cannabis convictions. Data like this is often perceived as another good motive to excuse cannabis related sentences, (particularly harsher convictions).

Research and Development 98

Research and Development Recreational Programs Cannabis 98

Veriheal

OCTOBER 14, 2022

Cannabis is notoriously combined with other substances, and of those combinations, few have been the topic of research. The study was published this year (2022) and begins by explaining that one out of four Canadians aged 15 years and older are using opioid therapy, like codeine, to alleviate their pain.

Cannabis 95

Cannabis Recreational Therapy Topical 95

Cannabis Law Report

MAY 12, 2022

Berman and Jana Hrdinová write May 11, 2022 . This number grew to 29 schools offering 33 courses in 2019-2020, and growth continued with 35 schools offering 35 courses in 2020-2021 and finally 37 schools offering 38 courses in our most recent accounting in 2021-2022. Edited by: Katherine Gemmingen | U. Pittsburgh School of Law, US.

Law 52

Law Policy State Laws Environment 52

Cannabis Law Report

DECEMBER 4, 2019

based company plans to sell softgels, oil drops, and topical cream products, according to the company’s website. “The FDA has seen only limited data about CBD safety and these data point to real risks that need to be considered before taking CBD for any reason,” the U.S. billion by 2022.

CBD 59

CBD Supply Chain Safety Hemp 59

Cannabis Law Report

NOVEMBER 29, 2021

As we approach the 2022 legislative session and the elections next November, it is important for lawmakers of all political persuasions to recognize that advocating for marijuana policy reforms is a political opportunity, not a political liability,” NORML’s Paul Armentano said. The law will take effect in January 2022. California.

Legislation 98

Legislation Patients Retail Access 98

Cannabis Law Report

JULY 24, 2022

The market research company Data Bridge Market Research projects that the market capitalization of the psychedelic industry will grow 16.8 The market research company Data Bridge Market Research projects that the market capitalization of the psychedelic industry will grow 16.8 percent annually to $9.8 billion by 2029. [1]

Research and Development 52

Research and Development Legalization Treatment Patients 52

The Cannigma

JANUARY 13, 2023

Edibles won’t produce the same experience, but topicals may be able to help, too. A review of existing endocannabinoid system and migraine research from March 2022 identified many surveys, but fewer clinical research trials, and even fewer double-blind placebo studies.

Terpenes 132

Terpenes Strains THC Treatment 132

Veriheal

AUGUST 31, 2021

The app would also provide data to producers and distributors to identify trends in the market to better serve the needs of consumers. . The design aims to gather and utilize data from the community’s own experiences to improve everyday diversity and discrimination issues in the industry. . Camille Elliott. Major/Program: Nursing.

Research and Development 116

Research and Development Supply Chain Programs Education 116

Veriheal

JANUARY 5, 2022

Young and Joyce’s letter places a lot of importance on being able to benefit from the therapeutic properties of cannabis as well as being able to get better—and more—data. Young’s Trail of Cannabis Reform. The pair conclude their letter by stating: “We can appreciate when leaders come from different concerns and priorities.

Legislation 52

Legislation Cannabis Therapy Access 52

Cannabis Law Report

NOVEMBER 4, 2021

The show presented several valuable workshops on critical topics including plant-based going mainstream, esports, supply chains, contract manufacturing, the path forward for hemp/CBD, immune health, the microbiome and natural sweeteners. SupplySide East 2022 will be held April 12-13 at the Meadowlands Exposition Center in Secaucus, NJ.

Food 40

Food Events Supply Chain Business 40

Cannabis Law Report

NOVEMBER 11, 2021

All data collected must be kept confidential. I would assume it’s a quieter session on this topic,” Garnett said. Dispensaries must enforce the daily purchase limits by inputting patient ID numbers found on medical marijuana cards. Stores are to refuse sale to anyone who seeks to exceed their purchase limit. Exceptions.

Concentrates 52

Concentrates Patients Access Conditions 52

Cannabis Law Report

OCTOBER 14, 2021

states, including in future adult-use markets in New York and New Jersey , prior to the end of calendar 2022. 1 Source: Headset data for tracked US states. Wana expects to have license agreements in place in more than 20 U.S. Strategic Benefits. Strengthens Canopy Growth’s U.S. cannabis market upon federal permissibility.

Edibles 52

Edibles Data Marijuana Events 52

Cannabis Law Report

AUGUST 4, 2021

We thus provide comparison with the pre-pandemic period of H1 2019 as an additional data point. At the time of FY 2020 results publication, we estimated that EUR 250m revenues had been lost in FY 2020 due to the impact of COVID-19 lockdowns and travel restrictions and the objective was to recover these revenues by 2022.

Business 105

Business Research and Development Environment Food 105

Cannabis Law Report

OCTOBER 6, 2021

The studies are expected to begin in January of 2022. Preliminary in-vitro, ex-vivo, and in-vivo data demonstrated that AnQlar inhibits replication of SARS-CoV-2 and may inhibit viral spread as well as viral brain load at non-toxic concentrations. Food and Drug Administration (“FDA”). About Virpax Pharmaceuticals.

Research and Development 52

Research and Development Clinical Trials Pharmaceutical Chronic Pain 52